29例小儿支原体肺炎喜炎平注射液辅助治疗观察

目的:对喜炎平注射液辅助治疗小儿支原体肺炎的临床疗效进行观察,不断改进治疗方法,提高治疗质量,保障患儿健康。方法:选择作者所在医院的58例小儿支原体肺炎患者作为研究对象,从1号到58号对他们进行排序,根据单双号将他们随机划分为观察组与对照组,两组人数均等,各29例,并保证两组患儿在各项临床数据上均无较大差异,具有可比性。两组患儿都接受相同的祛痰、平喘、止咳、退热以及阿奇霉素治疗,所不同的是进一步予以观察组患儿喜炎平进行辅助治疗,并根据相关标准对两组患儿的疗效进行统计与对比。结果:经临床治疗,观察组患儿治疗的总有效率为96.55%,对照组患儿为89.66%,对比差异明显,具有统计学意义。另外,在止咳时间、退热时间以及X线恢复时间与住院时间上,观察组明显优于对照组,对比差异具有统计学意义。结论:采用喜炎平辅助治疗小儿支原体肺炎,能够取得良好的治疗效果,具有临床推广和实践的价值与意义。

Objective：To assist Xiyanping injection Mycoplasma pneumoniae clinical efficacy were observed. Methods：58 patients with mycoplasma pneumonia select authors hospital as the research object, they were randomly divided into observation group and control group, 29 cases of two persons each. Two groups of children have received the same treatment with azithromycin, the difference is to be further observed group of children Xiyanping adjuvant therapy, and in accordance with relevant standards on the efficacy of two groups of children for statistical and contrast. Results：The clinical observation of clinical treatment groups were significantly better than the control group, a statistically significant comparative differences are significant. Conclusion：Xiyanping adjuvant treatment of mycoplasma pneumonia, can achieve a more favorable therapeutic effect, have value and significance of clinical and practice.